Prescription assessment responsibilities

Because pharmacists are responsible for all phases of medication use, processes in the pharmacy can refer to any phase of the medication use process (e.g., prescribing, dispensing, administering, or monitoring). Examples of process measures include, but are not limited to, adherence to clinical guidelines or pathways, percent of prescriptions assessed for appropriateness, and percent of patients counseled. 

In pharmacy preparation the very first step of Product realisation is the prescription assessment for an individual patient or the benefit/risk assessment (and definition of indications) for a stock preparation. See Sect. 2.2 for the performance of this step and for the assignment of responsibilities. 

Obtain a thorough medication use history, including present and past drugs prescription and nonprescription drugs the patient s self-assessment of response and side-effect problems use of alcohol, tobacco, caffeine, and illicit substances and use of herbal products and dietary supplements, as well as any allergies and adherence difficulties. 

Clients who suffer from psychosis vary greatly in their responses to medication and other forms of intervention. Therefore, most primary-care practitioners steer away from prescribing medicine for these individuals, although primary care and general medicine physicians often treat conditions such as depression. One major aspect of treatment expectations is that the client with a psychotic disorder is rarely given a prescription and sent home. After assessing the client, extensive monitoring and support... 

The recommendation and subsequent implantation of a pacemaker constitutes a therapeutic prescription with the same long-term responsibility for the periodic assessment of the continued appropriateness of that therapy as with the prescription of any pharmacologic agent. The multiplicity of programmable options available in the modem pacemaker allows the physician to titrate the dose of pacing in a manner similar to the periodic adjustment of the dose of a medication. A prime example is renal failure which commonly requires a decrease in the dose of some medications necessitated by a reduction in renal clearance, this same condition may require an increase in the programmed output of the pacemaker if the patient is prone to hyperkalania because of associated rises in the capture threshold. 

Part 2 and its chapters presented the topic of human lead exposure in global and categorical terms, addressing the technical areas of lead intakes, uptakes (absorption), toxicokinetics, integration of toxicokinetics into in vivo disposition in a manner allowing quantitative assessments of lead exposure, etc. In contrast to these broadly descriptive aspects of human Pb exposme, the applied health discipline of quantitative risk assessment requires prescriptive approaches for site-specific, case-specific, and environmental scenario-specific lead exposure characterizations. Data from such specific exposure characterizations are combined with available data for lead dose—response relationships to arrive at some quantitative risk characterization indexed as some endpoint for human health risk. 

---